This unique book provides a thorough overview of developing molecular cancer
diagnostic assays, which are the prerequisites for optimal solutions within
personalized cancer medicine. Journeying through definitions of the
pharmacodiagnostic concept, the guide also explores historical perspectives of
the early steps into molecular cancer diagnostics linked to therapy, the basis
of different diagnostic molecular techniques, ongoing research, drug-diagnostic
co-development, assay validation, clinical trial methodology, regulatory issues
around pharmacodiagnostics, and future aspects within personalized cancer
medicine. The first of its kind to cover relevant subjects around molecular
cancer diagnostics when used as important drivers in personalized cancer
medicine, the book´s different chapters are written by key opinion leaders,
each representing their specialized areas and expertise knowledge in the field.
